TTK and cancer: TTK, a dual‐specific protein kinase, can phosphorylate tyrosine, serine, and threonine.[12] Recent research has implicated TTK in tumorigenesis and the metastatic progression of several cancer types, where it contributes to poor clinical outcomes through diverse mechanisms.[18, 19] Our study revealed that TTK promoted the phenotypic switching of VSMCs.